Mark Clendenning

9.6k total citations · 1 hit paper
63 papers, 2.9k citations indexed

About

Mark Clendenning is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mark Clendenning has authored 63 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 39 papers in Oncology and 30 papers in Cancer Research. Recurrent topics in Mark Clendenning's work include Genetic factors in colorectal cancer (50 papers), Colorectal Cancer Screening and Detection (32 papers) and Cancer Genomics and Diagnostics (26 papers). Mark Clendenning is often cited by papers focused on Genetic factors in colorectal cancer (50 papers), Colorectal Cancer Screening and Detection (32 papers) and Cancer Genomics and Diagnostics (26 papers). Mark Clendenning collaborates with scholars based in Australia, United States and Canada. Mark Clendenning's co-authors include Daniel D. Buchanan, Mark A. Jenkins, John L. Hopper, Christophe Rosty, Albert de la Chapelle, Heather Hampel, Aung Ko Win, Kaisa Sotamaa, Joanne Young and Graham G. Giles and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Mark Clendenning

60 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer

2008 612 citations Heather Hampel, Wendy L. Frankel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Clendenning Australia	25	2.1k	1.8k	1.1k	614	419	63	2.9k
Kelsey Moyes United States	8	2.0k 0.9×	1.6k 0.9×	1.1k 1.0×	552 0.9×	401 1.0×	17	2.8k
Brian Allen United States	17	1.4k 0.7×	1.2k 0.7×	946 0.9×	675 1.1×	206 0.5×	39	2.4k
Paulo Fidalgo Portugal	19	1.1k 0.5×	778 0.4×	380 0.4×	422 0.7×	374 0.9×	45	1.6k
Virgı́nia Piñol Spain	19	1.1k 0.5×	1.3k 0.8×	467 0.4×	258 0.4×	341 0.8×	41	1.8k
Susanne Taucher Austria	23	456 0.2×	1.1k 0.6×	954 0.9×	316 0.5×	221 0.5×	45	1.7k
Tina Bocker Edmonston United States	21	818 0.4×	795 0.4×	441 0.4×	399 0.6×	273 0.7×	43	1.5k
Mara Fornasarig Italy	20	817 0.4×	787 0.4×	361 0.3×	253 0.4×	434 1.0×	55	1.4k
Susan Parry New Zealand	18	1.1k 0.5×	1.4k 0.8×	221 0.2×	307 0.5×	373 0.9×	45	1.9k
Tiemo Katzenberger Germany	29	1.8k 0.9×	1.2k 0.7×	183 0.2×	451 0.7×	230 0.5×	54	2.5k
Kuk Jin Choe South Korea	25	380 0.2×	926 0.5×	458 0.4×	447 0.7×	470 1.1×	71	2.0k

Countries citing papers authored by Mark Clendenning

Since Specialization

Citations

This map shows the geographic impact of Mark Clendenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Clendenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Clendenning more than expected).

Fields of papers citing papers by Mark Clendenning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Clendenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Clendenning. The network helps show where Mark Clendenning may publish in the future.

Co-authorship network of co-authors of Mark Clendenning

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Clendenning. A scholar is included among the top collaborators of Mark Clendenning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Clendenning. Mark Clendenning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joo, Jihoon E., Khalid Mahmood, Mark Clendenning, et al.. (2025). Causes of DNA mismatch repair deficiency in sebaceous skin lesions demonstrating loss of MLH1 protein expression: constitutional over somatic MLH1 promoter methylation. Familial Cancer. 24(2). 36–36.

Clendenning, Mark, Jihoon E. Joo, Khalid Mahmood, et al.. (2023). A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report. Familial Cancer. 22(4). 423–428. 2 indexed citations

Saya, Sibel, Jennifer McIntosh, Ingrid Winship, et al.. (2020). A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care?. Public Health Genomics. 23(3-4). 110–121. 14 indexed citations

Nguyen‐Dumont, Tú, Jason A. Steen, Ingrid Winship, et al.. (2020). Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer. Familial Cancer. 19(3). 197–202. 5 indexed citations

Buchanan, Daniel D., Mark Clendenning, Christophe Rosty, et al.. (2018). Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1 (vol 20, pg 890, 2018). Genetics in Medicine. 20(10). 3 indexed citations

Parry, Susan, Randall W. Burt, Aung Ko Win, et al.. (2017). Reducing the polyp burden in serrated polyposis by serial colonoscopy: the impact of nationally coordinated community surveillance.. PubMed. 130(1451). 57–67. 11 indexed citations

Dienstmann, Rodrigo, Mike J. Mason, Frank A. Sinicrope, et al.. (2017). Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Annals of Oncology. 28(5). 1023–1031. 166 indexed citations

Clendenning, Mark, Harindra Jayasekara, Susan Preston, et al.. (2017). Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas. Familial Cancer. 17(1). 91–100. 20 indexed citations

Buchanan, Daniel D., Mark Clendenning, Christophe Rosty, et al.. (2017). Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1. Genetics in Medicine. 20(8). 890–895. 40 indexed citations

10.

Wang, Fan, Robert W. Rapkins, Robyn L. Ward, et al.. (2016). SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT -Methylated Colorectal Cancer. Clinical Cancer Research. 22(24). 6266–6277. 20 indexed citations

11.

Win, Aung Ko, James G. Dowty, Daniel D. Buchanan, et al.. (2015). 1054 Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. European Journal of Cancer. 51. S163–S163. 9 indexed citations

12.

Rosty, Christophe, et al.. (2014). Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome). SHILAP Revista de lepidopterología. 1 indexed citations

13.

Rosty, Christophe, Elizabeth Williamson, Mark Clendenning, et al.. (2014). Should the grading of colorectal adenocarcinoma include microsatellite instability status?. Human Pathology. 45(10). 2077–2084. 39 indexed citations

14.

Rosty, Christophe, et al.. (2013). Genitourinary. Laboratory Investigation. 93. 190–263. 1 indexed citations

15.

Walsh, Michael D., Mark Clendenning, Elizabeth Williamson, et al.. (2013). Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Modern Pathology. 26(12). 1642–1656. 122 indexed citations

16.

Walters, Rhiannon, Elizabeth Williamson, Dallas R. English, et al.. (2013). Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer. Epigenetics. 8(7). 748–755. 38 indexed citations

17.

Walsh, ⁄, et al.. (2010). Origin of colorectal cancers in high-risk serrated neoplasia patients. Journal of Gastroenterology and Hepatology. 25. 3 indexed citations

18.

Clendenning, Mark, Shuying Sun, Kyle M. Walsh, et al.. (2008). Origins and Prevalence of the American Founder Mutation of MSH2. Cancer Research. 68(7). 2145–2153. 29 indexed citations

19.

Gururangan, Sridharan, Wendy L. Frankel, Russell Broaddus, et al.. (2007). Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation. Neuro-Oncology. 10(1). 93–97. 19 indexed citations

20.

Clendenning, Mark, Heather Hampel, Annika Lindblom, et al.. (2006). Long-range PCR facilitates the identification ofPMS2-specific mutations. Human Mutation. 27(5). 490–495. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact